A Study to Evaluate the Safety and Efficacy of Image Guided Surgery using Indocyanine Green for Intramolecular Imaging of Solid Tumors Compared to Standard of Care (TumorGlow) (PRIME)
Recruiting
99 years or below
All
Phase
2
500 participants needed
1 Location
Brief description of study
Indocyanine Green (ICG) is an FDA approved, water-soluble tricarbocyanine dye routinely used in
clinical settings for measuring cardiac output, liver function, and retinal angiography and has been in
use for over 50 years. Patient diagnosed with solid tumor cancers have a high rate of recurrence when
surgery is a treatment. The high rates of recurrence suggest that surgeons are unable to completely
detect and remove primary tumor nodules in a satisfactory manner as well as lingering metastases in
sentinel lymph nodes. There is some data to suggest that near infrared imaging can can improve on
negative margins.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: 99 years or below
-
Gender: All
Updated on
09 Apr 2021.
Study ID: 844554
